RNA Editing Gordon Research Conference (GRC) Presentation … RNA Editing Gordon Research Conference (GRC) Oral presentation title: Development of RNA editing oligonucleotides technology to address liver … März 23, 2023
ProQR Update August 2022 Community news … will focus exclusively on the development of the Axiomer® RNA editing technology platform across multiple therapeutic … August 11, 2022
ProQR at TIDES to highlight our Axiomer® technology Blog … Conference (TIDES Europe) 2022 to highlight our Axiomer® RNA-editing platform technology. This month several ProQRians … November 17, 2022
Exploring why companies partner their technology Blog … on developing potential medicines using our Axiomer ® RNA editing platform technology. Strategic collaborations … Januar 03, 2023
Catching up with returning ProQRian René Beukema Blog In this personal interview, we speak to ProQR’s Chief Corporate Development Officer & General Counsel, René Beukema on his return to ProQR. Februar 09, 2023
ProQR welcomes a new generation of scientists Blog … the industry. Leiden student learning about our Axiomer™ RNA editing technology. The visit began with general … Februar 21, 2024
RNA Leaders Europe Congress Presentation … RNA Leaders Europe Congress Oral presentation title: … potential of Axiomer® platform to develop transformative RNA editing therapies Presenter: Daniel A. de Boer, Founder and … März 16, 2023
Oligonucleotide and Precision Therapeutics (OPT) Congress Congress … Oral presentation title: Therapeutic potential of an RNA editing platform using Editing Oligonucleotides (EONs) … März 14, 2023
ProQR Therapeutics Virtual R&D Event 2023 Webcast … event, the Company will showcase its proprietary Axiomer ® RNA-editing technology platform, announce initial pipeline … März 29, 2023
Today marks an expansion of the ProQR and Lilly partnership News update … on developing potential medicines using our Axiomer RNA editing platform technology. Strategic collaborations … Dezember 22, 2022
